The Cigna Group (NYSE:CI) Price Target Increased to $348.00 by Analysts at Wells Fargo & Company

The Cigna Group (NYSE:CIGet Free Report) had its target price raised by analysts at Wells Fargo & Company from $334.00 to $348.00 in a research note issued on Tuesday, Benzinga reports. The firm presently has an “equal weight” rating on the health services provider’s stock. Wells Fargo & Company‘s price target indicates a potential upside of 5.28% from the company’s previous close.

CI has been the subject of several other reports. Jefferies Financial Group upgraded The Cigna Group from a “hold” rating to a “buy” rating and lifted their price objective for the company from $335.00 to $341.00 in a report on Monday, December 11th. StockNews.com upgraded shares of The Cigna Group from a “buy” rating to a “strong-buy” rating in a report on Friday, November 3rd. Oppenheimer reiterated an “outperform” rating and issued a $360.00 target price on shares of The Cigna Group in a report on Wednesday, January 17th. Cantor Fitzgerald upgraded shares of The Cigna Group from a “neutral” rating to an “overweight” rating and boosted their target price for the stock from $334.00 to $372.00 in a report on Monday. Finally, Sanford C. Bernstein upgraded shares of The Cigna Group from a “market perform” rating to an “outperform” rating and boosted their target price for the stock from $330.00 to $372.00 in a report on Thursday, January 4th. Three investment analysts have rated the stock with a hold rating, ten have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, The Cigna Group currently has an average rating of “Moderate Buy” and a consensus target price of $352.47.

Check Out Our Latest Report on The Cigna Group

The Cigna Group Stock Up 0.9 %

Shares of CI opened at $330.55 on Tuesday. The firm has a market capitalization of $96.73 billion, a P/E ratio of 19.01, a P/E/G ratio of 1.01 and a beta of 0.51. The Cigna Group has a 12-month low of $240.50 and a 12-month high of $333.86. The company has a current ratio of 0.67, a quick ratio of 0.71 and a debt-to-equity ratio of 0.61. The firm has a fifty day moving average price of $298.35 and a 200-day moving average price of $293.20.

The Cigna Group (NYSE:CIGet Free Report) last released its quarterly earnings data on Friday, February 2nd. The health services provider reported $6.79 earnings per share for the quarter, beating the consensus estimate of $6.54 by $0.25. The firm had revenue of $51.15 billion during the quarter, compared to the consensus estimate of $48.91 billion. The Cigna Group had a return on equity of 13.59% and a net margin of 2.64%. The firm’s quarterly revenue was up 11.8% on a year-over-year basis. During the same period in the previous year, the company posted $4.96 earnings per share. Equities research analysts expect that The Cigna Group will post 28.35 earnings per share for the current year.

Institutional Investors Weigh In On The Cigna Group

Large investors have recently modified their holdings of the stock. Bogart Wealth LLC grew its holdings in The Cigna Group by 104.5% in the third quarter. Bogart Wealth LLC now owns 90 shares of the health services provider’s stock valued at $26,000 after purchasing an additional 46 shares during the last quarter. OFI Invest Asset Management acquired a new stake in shares of The Cigna Group during the third quarter valued at $26,000. Fairfield Bush & CO. acquired a new stake in shares of The Cigna Group during the second quarter valued at $28,000. Fortitude Family Office LLC acquired a new stake in shares of The Cigna Group during the fourth quarter valued at $29,000. Finally, Optimum Investment Advisors boosted its stake in shares of The Cigna Group by 110.0% during the third quarter. Optimum Investment Advisors now owns 105 shares of the health services provider’s stock valued at $30,000 after acquiring an additional 55 shares during the last quarter. Hedge funds and other institutional investors own 85.32% of the company’s stock.

The Cigna Group Company Profile

(Get Free Report)

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.

See Also

Analyst Recommendations for The Cigna Group (NYSE:CI)

Receive News & Ratings for The Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.